EPLONTERSEN
Drug Details
- Generic Name
- EPLONTERSEN
- Brand Names
- WAINUA
- Application Number
- NDA217388
- Sponsor
- AstraZeneca Pharmaceuticals LP
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- EPLONTERSEN
Indications and Usage
1 INDICATIONS AND USAGE WAINUA is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. WAINUA is a transthyretin-directed antisense oligonucleotide indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. ( 1 )